Literature DB >> 7679004

CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro.

D Delia1, M G Lampugnani, M Resnati, E Dejana, A Aiello, E Fontanella, D Soligo, M A Pierotti, M F Greaves.   

Abstract

Freshly cultured vascular endothelial cells express the CD34 antigen in a diffuse cell surface pattern with some concentration on microvilli. Expression is downregulated with proliferation in continuous culture and undetectable after nine population doublings but can be maintained by restraining cell proliferation and promoting cell contact. Expression of CD34 at the antigen and mRNA levels on early passage cells is rapidly downregulated by interleukin-1 beta (IL-1 beta), interferon-gamma (INF-gamma), and tumor necrosis factor-alpha (TNF-alpha) under conditions in which these ligands upregulate the adhesion molecules: endothelial leukocyte adhesion molecule 1 (ELAM-1) and intracellular adhesion molecule 1 (ICAM-1). This reciprocal pattern of expression and the topographic distribution of CD34 molecules on the lumenal interdigitated microprocesses of adjacent endothelial cells in vivo suggest that CD34 might have a negative modulating role on adhesion functions of endothelia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679004

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

Review 1.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

Review 2.  L-Selectin ligands in lymphoid tissues and models of inflammation.

Authors:  Adil I Khan; R Clive Landis; Rajneesh Malhotra
Journal:  Inflammation       Date:  2003-10       Impact factor: 4.092

3.  Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes.

Authors:  Franck Festy; Laurence Hoareau; Sandrine Bes-Houtmann; Anne-Marie Péquin; Marie-Paule Gonthier; Ashik Munstun; Jean Jacques Hoarau; Maya Césari; Régis Roche
Journal:  Histochem Cell Biol       Date:  2005-09-29       Impact factor: 4.304

Review 4.  Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis.

Authors:  Sebastian George Barton Furness; Kelly McNagny
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Transdifferentiation of peripheral blood mononuclear cells into epithelial-like cells.

Authors:  Abelardo Medina; Ruhangiz T Kilani; Nicholas Carr; Erin Brown; Aziz Ghahary
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

6.  Regulation of cell shape and adhesion by CD34.

Authors:  Hiroe Ohnishi; Hiroyuki Sasaki; Yoshihiko Nakamura; Shunichi Kato; Kiyoshi Ando; Hisashi Narimatsu; Kouichi Tachibana
Journal:  Cell Adh Migr       Date:  2013-08-05       Impact factor: 3.405

7.  Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury.

Authors:  Junichi Hirahashi; Keiichi Hishikawa; Shinya Kaname; Naotake Tsuboi; Yunmei Wang; Daniel I Simon; George Stavrakis; Tatsuo Shimosawa; Ling Xiao; Yutaka Nagahama; Kazuo Suzuki; Toshiro Fujita; Tanya N Mayadas
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

Review 8.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

9.  Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.

Authors:  Banafsheh Nazari; Lisa M Rice; Giuseppina Stifano; Alexander M S Barron; Yu Mei Wang; Tess Korndorf; Jungeun Lee; Jag Bhawan; Robert Lafyatis; Jeffrey L Browning
Journal:  Am J Pathol       Date:  2016-08-23       Impact factor: 4.307

10.  Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.

Authors:  H Wildiers; G Guetens; G De Boeck; E Verbeken; B Landuyt; W Landuyt; E A de Bruijn; A T van Oosterom
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.